267 related articles for article (PubMed ID: 17337192)
1. A synthetic method for diversification of the P1' substituent in phosphinic dipeptides as a tool for exploration of the specificity of the S1' binding pockets of leucine aminopeptidases.
Vassiliou S; Xeilari M; Yiotakis A; Grembecka J; Pawełczak M; Kafarski P; Mucha A
Bioorg Med Chem; 2007 May; 15(9):3187-200. PubMed ID: 17337192
[TBL] [Abstract][Full Text] [Related]
2. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
Grembecka J; Mucha A; Cierpicki T; Kafarski P
J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
[TBL] [Abstract][Full Text] [Related]
3. Individual stereoisomers of phosphinic dipeptide inhibitor of leucine aminopeptidase.
Mucha A; Lämmerhofer M; Lindner W; Pawełczak M; Kafarski P
Bioorg Med Chem Lett; 2008 Mar; 18(5):1550-4. PubMed ID: 18262419
[TBL] [Abstract][Full Text] [Related]
4. Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds.
Skinner-Adams TS; Lowther J; Teuscher F; Stack CM; Grembecka J; Mucha A; Kafarski P; Trenholme KR; Dalton JP; Gardiner DL
J Med Chem; 2007 Nov; 50(24):6024-31. PubMed ID: 17960925
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.
Matziari M; Beau F; Cuniasse P; Dive V; Yiotakis A
J Med Chem; 2004 Jan; 47(2):325-36. PubMed ID: 14711305
[TBL] [Abstract][Full Text] [Related]
6. alpha-Aminoalkylphosphonates as a tool in experimental optimisation of P1 side chain shape of potential inhibitors in S1 pocket of leucine- and neutral aminopeptidases.
Drag M; Grembecka J; Pawełczak M; Kafarski P
Eur J Med Chem; 2005 Aug; 40(8):764-71. PubMed ID: 16122579
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of α-carboxyphosphinopeptides derived from norleucine.
Pícha J; Buděšínský M; Fiedler P; Sanda M; Jiráček J
Amino Acids; 2010 Nov; 39(5):1265-80. PubMed ID: 20349321
[TBL] [Abstract][Full Text] [Related]
8. Substrate recognition and selectivity of peptide deformylase. Similarities and differences with metzincins and thermolysin.
Ragusa S; Mouchet P; Lazennec C; Dive V; Meinnel T
J Mol Biol; 1999 Jun; 289(5):1445-57. PubMed ID: 10373378
[TBL] [Abstract][Full Text] [Related]
9. Engineering the S1' subsite of trypsin: design of a protease which cleaves between dibasic residues.
Kurth T; Grahn S; Thormann M; Ullmann D; Hofmann HJ; Jakubke HD; Hedstrom L
Biochemistry; 1998 Aug; 37(33):11434-40. PubMed ID: 9708978
[TBL] [Abstract][Full Text] [Related]
10. Novel hydroxamic acid-related phosphinates: inhibition of neutral aminopeptidase N (APN).
Drag M; Grzywa R; Oleksyszyn J
Bioorg Med Chem Lett; 2007 Mar; 17(6):1516-9. PubMed ID: 17270439
[TBL] [Abstract][Full Text] [Related]
11. [Affinity labeling of leucine aminopeptidase with new substrate analog inhibitors].
Fittkau S; Schunck WH; Mootsi S
Acta Biol Med Ger; 1976; 35(3-4):365-78. PubMed ID: 970045
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position.
Tucker TJ; Brady SF; Lumma WC; Lewis SD; Gardell SJ; Naylor-Olsen AM; Yan Y; Sisko JT; Stauffer KJ; Lucas BJ; Lynch JJ; Cook JJ; Stranieri MT; Holahan MA; Lyle EA; Baskin EP; Chen IW; Dancheck KB; Krueger JA; Cooper CM; Vacca JP
J Med Chem; 1998 Aug; 41(17):3210-9. PubMed ID: 9703466
[TBL] [Abstract][Full Text] [Related]
13. P1' Residue-Oriented Virtual Screening for Potent and Selective Phosphinic (Dehydro) Dipeptide Inhibitors of Metallo-Aminopeptidases.
Talma M; Mucha A
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32344658
[TBL] [Abstract][Full Text] [Related]
14. A structural insight into the P1S1 binding mode of diaminoethylphosphonic and phosphinic acids, selective inhibitors of alanine aminopeptidases.
Węglarz-Tomczak E; Berlicki Ł; Pawełczak M; Nocek B; Joachimiak A; Mucha A
Eur J Med Chem; 2016 Jul; 117():187-96. PubMed ID: 27100031
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and metal binding of novel Pseudo- oligopeptides containing two phosphinic acid groups.
Ye Y; Liu M; Kao JL; Marshall GR
Biopolymers; 2008 Jan; 89(1):72-85. PubMed ID: 17910046
[TBL] [Abstract][Full Text] [Related]
16. Efficient synthesis of Fmoc-protected phosphinic pseudodipeptides: Building blocks for the synthesis of matrix metalloproteinase inhibitors.
Bhowmick M; Sappidi RR; Fields GB; Lepore SD
Biopolymers; 2011; 96(1):1-3. PubMed ID: 20225219
[TBL] [Abstract][Full Text] [Related]
17. Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2.
Mores A; Matziari M; Beau F; Cuniasse P; Yiotakis A; Dive V
J Med Chem; 2008 Apr; 51(7):2216-26. PubMed ID: 18324760
[TBL] [Abstract][Full Text] [Related]
18. Conformational and solvation studies via computer simulation of the novel large scale diastereoselectively synthesized phosphinic MMP inhibitor RXP03 diluted in selected solvents.
Matziari M; Dellis D; Dive V; Yiotakis A; Samios J
J Phys Chem B; 2010 Jan; 114(1):421-8. PubMed ID: 20014753
[TBL] [Abstract][Full Text] [Related]
19. Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases.
Vassiliou S; Węglarz-Tomczak E; Berlicki Ł; Pawełczak M; Nocek B; Mulligan R; Joachimiak A; Mucha A
J Med Chem; 2014 Oct; 57(19):8140-51. PubMed ID: 25192493
[TBL] [Abstract][Full Text] [Related]
20.
Janiszewska K; Talma M; Oszywa B; Pawełczak M; Kafarski P; Mucha A
Molecules; 2020 Sep; 25(18):. PubMed ID: 32971789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
